← All companies

BIVI — BIOVIE INC.

Materials · Pharmaceutical Preparations · Nasdaq

CIK 0001580149 · FYE 0630 · All Form 4 filings on EDGAR ↗

Formerly: NANOANTIBIOTICS, INC. (until 2016-07-22)

4Insiders filing

4Transactions

+$49kReported buys

−$0Reported sells

0Cluster events

Window in data: 2026-08-27 → 2026-08-28 · Data as of 2026-08-31

Insiders

Insider	Role	Txns	Reported value
DO CUONG V	President & CEO	1	$32k
Palumbo Joseph M	Chief Medical Officer	1	$10k
KIM JOANNE WENDY	Chief Financial Officer	1	$5k
Chappell Amy Suzon	Director	1	$2k

Transaction history

Filing date	Trade date	Ticker	Insider	Type	Shares	Price	Value	Cluster
2026-08-28	2026-08-28	BIVI	Palumbo Joseph M Chief Medical Officer	P	4,843	$2.16	+$10k	—
2026-08-28	2026-08-28	BIVI	Chappell Amy Suzon Director	P	727	$2.16	+$2k	—
2026-08-28	2026-08-28	BIVI	KIM JOANNE WENDY Chief Financial Officer	P	2,500	$2.18	+$5k	—
2026-08-28	2026-08-27	BIVI	DO CUONG V President & CEO	P	15,210	$2.08	+$32k	—

Known data limitations

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Insider Atlas is a descriptive research site, not investment advice — see the methodology for the full provenance chain.